circus in the philippines
Include PWDs in your holiday plans, MP asks KenyansWhat were the issues disability worker Charlotte Fallon was trying to raise with Simon Harris?
Kia to launch compact SUV ‘Syros’ in India next yearMumbai : Market regulator, the Securities and Exchange Board of India (SEBI) has taken strict action in a front-running case, banning PNB Met Life Insurance Company's equity dealer Sachin Bakul Dagli and eight other entities from the stock market. According to the SEBI, front running was being done by Dagli and eight entities for more than three years and during this period, all of them collectively earned illegal profits of Rs 21.16 crore. The market regulator banned Dagli and the eight entities from the stock market and seized the unlawful gains. The SEBI had investigated some suspicious front-running trades related to PNB MetLife India Insurance before this action. The focus of this investigation was to find out whether the suspicious entities were doing front running in the trade of PNB MetLife India Insurance with the help of other people, including dealers and fund managers. It also sought to find whether SEBI rules have been violated or not. The investigation, which was conducted from January 1, 2021, to July 19, 2024, revealed that most of the trading decisions at PNB MetLife were assigned to Dagli for execution. The investigation found that Dagli, the equity dealer of PNB MetLife, and his brother Tejas Dagli, an equity sales trader at Investec, obtained confidential, non-public information about the upcoming trading decisions of PNB MetLife and Investec. This information was further used to make trading decisions and shared with Sandeep Shambharkar, who executed front-running trades through the accounts of Dhanmata Realty Private Ltd (DRPL), Worthy Distributors Private Ltd (WDPL), and Pragnesh Sanghvi. DRPL and WDPL Directors Arpan Kirtikumar Shah, Kabita Saha, and Jignesh Nikulbhai Dabhi were also involved in carrying out this task. The SEBI said that 6,766 front-running trades have been executed. A profit of Rs 21,15,78,005 was earned from this. PNB MetLife, in its statement given to IANS, said: "Company has fully cooperated with the authorities in this matter and wants to thank SEBI for the conclusion of its findings of fraud by the named individual against PNB MetLife. In line with our internal processes, we have taken disciplinary action." "PNB MetLife is committed to upholding the highest standards of corporate governance, transparency, and integrity," the company added. Front-running is an illegal practice, entailing a trader or broker receiving confidential information about a large company or institution making a bulk order in a particular stock and creating a position in that particular stock before the big order is executed. In such a situation, when the order is executed by a big company or institution, the trader or broker gets the benefit of the sudden rise in that stock.MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND
NoneMidAtlantic Capital Management Inc. purchased a new stake in shares of JPMorgan Chase & Co. ( NYSE:JPM ) during the third quarter, HoldingsChannel.com reports. The institutional investor purchased 643 shares of the financial services provider’s stock, valued at approximately $136,000. Several other hedge funds and other institutional investors have also made changes to their positions in the business. Mizuho Securities Co. Ltd. acquired a new position in JPMorgan Chase & Co. during the 3rd quarter valued at about $25,000. Catalyst Capital Advisors LLC acquired a new stake in shares of JPMorgan Chase & Co. in the 3rd quarter worth approximately $27,000. Fairway Wealth LLC bought a new position in shares of JPMorgan Chase & Co. in the second quarter valued at approximately $32,000. Anfield Capital Management LLC acquired a new position in shares of JPMorgan Chase & Co. during the second quarter valued at approximately $34,000. Finally, West Financial Advisors LLC bought a new stake in JPMorgan Chase & Co. during the third quarter worth approximately $37,000. 71.55% of the stock is currently owned by institutional investors and hedge funds. JPMorgan Chase & Co. Price Performance Shares of NYSE:JPM opened at $248.56 on Friday. The stock has a market capitalization of $699.78 billion, a P/E ratio of 13.83, a P/E/G ratio of 3.53 and a beta of 1.10. The business has a 50-day moving average of $223.14 and a two-hundred day moving average of $211.76. JPMorgan Chase & Co. has a fifty-two week low of $152.71 and a fifty-two week high of $249.15. The company has a debt-to-equity ratio of 1.27, a current ratio of 0.89 and a quick ratio of 0.89. JPMorgan Chase & Co. Increases Dividend The company also recently announced a quarterly dividend, which was paid on Thursday, October 31st. Investors of record on Friday, October 4th were paid a $1.25 dividend. The ex-dividend date of this dividend was Friday, October 4th. This is a positive change from JPMorgan Chase & Co.’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a yield of 2.01%. JPMorgan Chase & Co.’s dividend payout ratio (DPR) is presently 27.82%. Analyst Upgrades and Downgrades A number of equities analysts have issued reports on JPM shares. Oppenheimer lowered JPMorgan Chase & Co. from an “outperform” rating to a “market perform” rating in a research note on Wednesday. Royal Bank of Canada lifted their target price on JPMorgan Chase & Co. from $211.00 to $230.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $235.00 price target on shares of JPMorgan Chase & Co. in a report on Tuesday, September 3rd. Wells Fargo & Company lifted their price objective on shares of JPMorgan Chase & Co. from $240.00 to $270.00 and gave the stock an “overweight” rating in a research note on Friday, November 15th. Finally, Daiwa Capital Markets cut their target price on shares of JPMorgan Chase & Co. from $240.00 to $235.00 and set an “overweight” rating for the company in a research note on Thursday, October 10th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $229.31. Read Our Latest Report on JPM JPMorgan Chase & Co. Profile ( Free Report ) JPMorgan Chase & Co operates as a financial services company worldwide. It operates through four segments: Consumer & Community Banking (CCB), Corporate & Investment Bank (CIB), Commercial Banking (CB), and Asset & Wealth Management (AWM). The CCB segment offers deposit, investment and lending products, cash management, and payments and services; mortgage origination and servicing activities; residential mortgages and home equity loans; and credit cards, auto loans, leases, and travel services to consumers and small businesses through bank branches, ATMs, and digital and telephone banking. Featured Stories Want to see what other hedge funds are holding JPM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan Chase & Co. ( NYSE:JPM – Free Report ). Receive News & Ratings for JPMorgan Chase & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan Chase & Co. and related companies with MarketBeat.com's FREE daily email newsletter .
American kids got a D- in physical activity. What does that mean? What can we do about it?
Isro to study how crops grow in space on PSLV-C60 missionTrump taps Charles Kushner, father of his son-in-law, as envoy to France